Open Government Portal
Found 10 records similar to 2021–22 Departmental Plan: Health Canada
COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.
Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.
"The Cyber Centre has seen an increase in reports of malicious actors using the CoronaVirus (COVID-19) in phishing campaigns and malware scams.
The response to COVID-19 is being led by Public Health Agency of Canada (PHAC), with support from public health officials and agencies across Canada. For information about COVID-19 please visit the Government of Canada’s COVID-19 Outbreak Update page for the most up to date information."
People with COVID-19 do not always recognize their early symptoms. Even if you do not have symptoms now, it is possible to transmit COVID-19 before you start showing symptoms or without ever developing symptoms. You need to quarantine (self-isolate) for 14 days at home when you may have been exposed to COVID-19 and have no symptoms.
COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical devices used to diagnose, treat or prevent COVID-19.
What being vaccinated against COVID-19 means for me. By getting vaccinated, you benefit from the protection you get against COVID-19 and the easing of restrictive measures in your community.
The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.
This dataset provides the cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction, vaccine product, and report date. Variables include:
Jurisdiction ID number
Cumulative number of COVID-19 vaccine doses administered
Cumulative number of Pfizer-BioNTech COVID-19 vaccine doses administered
Cumulative number of Moderna COVID-19 vaccine doses administered
Cumulative number of COVID-19 vaccine (unknown product) doses administered
As of date
For variable definitions, see the data dictionary. For details regarding data sources and limitations, see the technical notes section of the Canadian COVID-19 vaccination coverage report (https://health-infobase.canada.ca/covid-19/vaccination-coverage/technical-notes.html).
The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.
COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.